← Back to catalogue

Global Reference Module 12

FDA UDI

Class II (US FDA UDI)

by Neuralynx, Inc.

Identity

Trade Name
Global Reference Module 12 FDA UDI
Generic Name
Electroencephalographic signal amplifier FDA UDI
Device Name
The Global Reference Module 12 provides Global Referencing to the ATLAS Neurophysiology System. It connects to the Global Reference Connection on the ATLAS Combo Board. FDA UDI
Model / Reference
Global Reference Module - 12 FDA UDI
Description
The Global Reference Module 12 provides Global Referencing to the ATLAS Neurophysiology System. It connects to the Global Reference Connection on the ATLAS Combo Board. FDA UDI

Identifiers

Catalog Number
31-0604-0054 FDA UDI
Primary DI / UDI-DI
00850011306628 FDA UDI
FDA Product Code
OMC FDA UDI
GMDN Term
Electroencephalographic signal amplifier FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
882.1400 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Electroencephalographic signal amplifier

Global Reference Module 12 by Neuralynx, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Electroencephalographic signal amplifier.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Neuralynx, Inc.

Sources (1)

  • FDA UDI e0fe81e4-8478-48c3-93de-0d12b26595e7 35 fields · synced Jun 8, 2026